Preeclampsia and cardiovascular risk

W Hermes1, F Van Kesteren, C J M De Groot

  • 1Department of Obstetrics and Gynecology, Medical Center Haaglanden and Vu University Medical CenterThe Hague, the Netherlands. herwie@mchaaglanden.nl

Minerva Ginecologica
|June 26, 2012
PubMed

Insights

Preeclampsia, a common pregnancy disorder, significantly increases a woman's risk for future cardiovascular disease. This review explores the links between preeclampsia and heart conditions, highlighting the need for further research.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Women's Health

Background:

  • Cardiovascular disease is the leading cause of death in women globally.
  • Preeclampsia is a common pregnancy complication characterized by hypertension and proteinuria.
  • Preeclampsia is increasingly recognized as a risk factor for long-term cardiovascular disease.

Purpose of the Study:

  • To review the current literature on the association between preeclampsia and cardiovascular disease.
  • To explore the underlying mechanisms linking preeclampsia to future heart conditions.
  • To highlight the importance of pregnancy as a screening period for cardiovascular risk.

Main Methods:

  • Literature review of recent studies on preeclampsia and cardiovascular disease.
  • Analysis of epidemiological data and clinical observations.
  • Synthesis of current understanding of the pathophysiological links.

Main Results:

  • Women with a history of preeclampsia, particularly early-onset, exhibit a higher risk of developing cardiovascular disease later in life.
  • Pregnancy serves as a physiological stress test, potentially unmasking underlying cardiovascular vulnerabilities.
  • The precise biological mechanisms connecting preeclampsia to cardiovascular disease remain under investigation.

Conclusions:

  • Preeclampsia is a significant predictor of future cardiovascular disease in women.
  • Early identification and management of women with preeclampsia may offer opportunities for cardiovascular risk reduction.
  • Further research is crucial to elucidate the shared pathways and inform preventative strategies.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...